14 January 2014 in Molecular Psychiatry
5 January 2016 in Translational Psychiatry
Cognitive functioning can be differentially modulated by components of the immune system. Interferon-γ (IFNγ) is a pro-inflammatory cytokine whose production is altered in many conditions displaying some degree of cognitive deficits, although its role in cognitive functioning is still unclear. Here we show that the absence of IFNγ selectively enhances cognitive behaviours in tasks in which the hippocampus is implicated. Moreover, the absence of IFNγ leads to volumetric and cell density changes that are restricted to the dorsal part of the hippocampus. In the dorsal hippocampus, the absence of this pro-inflammatory cytokine leads to an increase in the numbers of newly born neurons in the subgranular zone of the dentate gyrus (DG), an adult neurogenic niche known to support learning and memory, and to an enlargement of the dendritic arborization of DG granule and cornu ammonis (CA)1 pyramidal neurons. Moreover, it also modestly impacts synaptic plasticity, by decreasing the paired-pulse facilitation in the Schaffer collateral to CA1 pyramidal cell synapses. Taken together, our results provide evidence that IFNγ is a negative regulator of hippocampal functioning, as its absence positively impacts on dorsal hippocampus structure, cell density, neuronal morphology and synaptic plasticity. Importantly, these neuroplastic changes are associated with improved performance in learning and memory tasks. Therefore, blockage of the IFNγ signalling may present as promising therapeutic targets for the treatment of inflammation-associated cognitive dysfunction.
6 February 2014 in Brain Structure and Function
2 September 2015 in Molecular Neurobiology
14 February 2019 in Scientific Reports
Aging is associated with cognitive decline. Herein, we studied a large cohort of old age and young adult male rats and confirmed that, as a group, old rats display poorer spatial learning and behavioral flexibility than younger adults. Surprisingly, when animals were clustered as good and bad performers, our data revealed that while in younger animals better cognitive performance was associated with longer dendritic trees and increased levels of synaptic markers in the hippocampus and prefrontal cortex, the opposite was found in the older group, in which better performance was associated with shorter dendrites and lower levels of synaptic markers. Additionally, in old, but not young individuals, worse performance correlated with increased levels of BDNF and the autophagy substrate p62, but decreased levels of the autophagy complex protein LC3. In summary, while for younger individuals “bigger is better”, “smaller is better” is a more appropriate aphorism for older subjects.
13 March 2025 in Journal of Endovascular Therapy
Purpose: Portal vein thrombosis (PVT) remains a significant clinical challenge with limited treatment options, particularly in patients at high risk of hemorrhage or intestinal infarction. In such cases, mechanical thrombectomy (MT) and catheter-directed thrombolysis (CDT), either as alternative treatments or in combination with systemic anticoagulation, may provide a more suitable approach. Case Report: Here, we present 3 cases of symptomatic acute/subacute PVT with concurrent mesenteric vein thrombosis, in which patients underwent MT and CDT. The procedures were technically successful in all cases, and patients were discharged without complications. Conclusion: In this report, we give recognition to the key effect that the endovascular intervention had on the treatment of 3 different patients with PVT, highlighting the value that the endovascular approach may add to the therapeutic armamentarium and further supporting its inclusion in current treatment guidelines. Clinical Impact: This study demonstrates the potential of endovascular interventions, such as MT and CDT, in treating PVT of high-risk patients. It offers a viable alternative to conventional treatments, enhancing clinical outcomes and supporting the inclusion of these techniques in updated treatment guidelines for PVT.